drugset / Trial / NCT01674686

The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm

NCT01674686

Phase 4 Unknown 200 enrolled Samsung Medical Center
RandomizedFactorialSingle-blindTreatment

Summary

The aim of the study was to to evaluate the effect of sarpogrelate, a selective serotonin receptor antagonist, and high dose statin on the reduction of coronary spasm in the patients with variant angina.

Timeline

Start
2012-08-01
Primary completion
2018-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg
Subject Sarpogrelate Small molecule 100 mg

Indications